Retrospective study on the safety and efficacy of pyrotinib in the treatment of HER2positive non-breast advanced solid tumors.

被引:0
|
作者
Wang, Jianzheng
Zhang, Baiwen
Cheng, Xiaojiao
Li, Qingli
Lv, Huifang
Nie, Caiyun
Chen, Beibei
Xu, Weifeng
Zhao, Jing
He, Yunduan
Tu, Shuiping
Chen, Xiaobing
机构
[1] Zhengzhou Univ, Henan Canc Hosp, Dept Gastrointestinal Med Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Oncol, Shanghai, Peoples R China
[3] Zheng zhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
15064
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Studies on the efficacy of pyrotinib in the treatment of HER-2 positive advanced solid tumors.
    Fan, Shaoshuang
    Jiang, Da
    Lv, Yalei
    Cui, Yanzhi
    Kong, Yan
    Dong, Qian
    Huang, Fang
    Zhang, Xue
    Wang, Long
    Zhou, Xinliang
    Jin, Hui
    Li, Ying
    Hou, Ran
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Studies on the Safety and Efficacy of Pyrotinib in the Treatment of HER2-Positive Advanced Solid Tumors Excluding Breast Cancer
    Yin, Yuzhen
    Yang, Hui
    Liu, Zhuo
    Tan, Jie
    Zhu, Chunrong
    Chen, Minbin
    Zhou, Rengui
    Wane, Lei
    Qian, Jun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 13479 - 13487
  • [3] Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors
    Wang, Jianzheng
    Zhang, Baiwen
    Cheng, Xiaojiao
    Li, Qingli
    Lv, Huifang
    Nie, Caiyun
    Chen, Beibei
    Xu, Weifeng
    Zhao, Jing
    He, Yunduan
    Tu, Shuiping
    Chen, Xiaobing
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [4] Efficacy and safety analysis of pyrotinib in lapatinib resistant HER2-positive metastatic breast cancer: A retrospective study
    Hua, Y.
    Yang, F.
    Yang, Y.
    Bao, S.
    Sun, C.
    Yan, X.
    Zeng, T.
    Jiang, M.
    Huang, X.
    Wu, H.
    Li, J.
    Li, W.
    Yin, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1262 - S1262
  • [5] A Retrospective Real-World Study of Pyrotinib in HER-2 Positive Advanced Breast Cancer
    Yang, Zhi
    Fu, Wei-Da
    Gu, Hua-Yan
    Ding, Jia-Ling
    Guo, Gui-Long
    CANCER MANAGEMENT AND RESEARCH, 2025, 17 : 441 - 460
  • [6] A pilot study of safety and efficacy of pandimex with or without paclitaxel in the treatment of advanced solid tumors.
    Ouyang, X
    Yu, Z
    Chen, Z
    Xie, F
    Fang, W
    Peng, Y
    Chen, X
    Chen, W
    Wang, W
    Qi, P
    Jia, W
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 238S - 238S
  • [7] Efficacy and Safety of Radiotherapy Combined with Pyrotinib in the Treatment of HER2-Positive Breast Cancer with Brain Metastases
    Huang, Jie
    Zhu, Wenqiang
    Duan, Qiangzhi
    Zhu, Chaomang
    Shi, Xueling
    Zhao, Hongyu
    Cai, Peng
    Li, Duojie
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 841 - 853
  • [8] Efficacy and safety of pyrotinib in combination with albumin-bound paclitaxel for the treatment of HER2-positive advanced breast cancer: A real-world study
    Yang, Lixian
    Zheng, Lei
    Kong, Fanting
    Tian, Xinli
    Zhang, Shiyu
    Pu, Pengpeng
    ONCOLOGY LETTERS, 2023, 26 (01)
  • [9] Efficacy, safety and translational study of pyrotinib combined with albuminbound paclitaxel as firstline treatment of HER-2 positive metastatic breast cancer
    Li, Huihui
    Man, Xiaochu
    Yin, Sha
    Zhou, Dongdong
    Zhang, Baoxuan
    Fang, Shu
    Zheng, Fangchao
    Li, Chao
    Wang, Xinzhao
    Huang, Wei
    Wang, Linlin
    He, Qingqing
    Fu, Hui
    Zhang, Yan
    Liu, Changrui
    Dong, Lin
    Zhao, Xianguang
    Xu, Liang
    Sun, Xiao
    Fan, Bingjie
    Song, Lihua
    Zhou, Zhengbo
    Tan, Qiaorui
    CANCER RESEARCH, 2024, 84 (09)
  • [10] TREATMENT SEQUENCING AND OVERALL SURVIVAL OF HER2POSITIVE ADVANCED BREAST CANCER IN A PERUVIAN INSTITUTION
    Valencia, Guillermo
    Rioja, Patricia
    Peralta, Olenka
    Chirito, Miguel
    Morante, Zaida
    Fuentes, Hugo
    Vidaurre, Tatiana
    Neciosup, Silvia
    Calderon, Monica
    Gomez, Henry L.
    BREAST, 2023, 71 : S50 - S51